Impact Partnership Wealth’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,061	Closed	-$284K	–	271
2024 Q2	$284K	Buy	+2,061	New	+$284K	0.07%	169
2023 Q3	–	Sell	-20	Closed	-$1.89K	–	1139
2023 Q2	$1.89K	Buy	+20	New	+$1.89K	﹤0.01%	691